1. Home
  2. NX vs AVDL Comparison

NX vs AVDL Comparison

Compare NX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$15.36

Market Cap

742.7M

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
AVDL
Founded
1927
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
742.7M
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
NX
AVDL
Price
$15.36
$21.63
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$28.00
$18.38
AVG Volume (30 Days)
1.2M
2.1M
Earning Date
12-11-2025
11-04-2025
Dividend Yield
2.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$248,517,000.00
Revenue This Year
$2.52
$65.47
Revenue Next Year
$3.29
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
43.81
79.88
52 Week Low
$11.04
$6.38
52 Week High
$25.41
$23.57

Technical Indicators

Market Signals
Indicator
NX
AVDL
Relative Strength Index (RSI) 57.12 61.54
Support Level $14.98 $21.36
Resistance Level $16.53 $21.68
Average True Range (ATR) 0.94 0.12
MACD 0.06 -0.12
Stochastic Oscillator 29.42 74.68

Price Performance

Historical Comparison
NX
AVDL

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: